Home » Articles posted by Multichannel Admin (Page 85)
Author Archives: Multichannel Admin
Blencowe Resources #BRES – Publication of a Prospectus
Blencowe is pleased to announce that its prospectus has been approved by the Financial Conduct Authority (the ‘FCA’) and published today by the Company (the ‘Prospectus’). The Prospectus relates to the admission of Placing Shares and Subscription Shares in connection with the £2,000,000 fundraise announced on 12 November 2021.
The Company will admit a total of 40,000,000 new ordinary shares to the standard listing segment of the Official List of the FCA and to trading on the Main Market for listed securities of the London Stock Exchange at 8.00 a.m. on 15 December 2021 (“Admission”). The new ordinary shares consist of 29,100,000 Placing Shares and 10,900,000 Subscription Shares. The Placing and the Subscription are conditional, inter alia, on Admission.
Further information is set out in the Prospectus, which can be accessed electronically from the Company’s website at www.blencoweresourcesplc.com.
Unless otherwise defined herein, terms defined in the Prospectus have the same meanings herein.
In accordance with the provision of the Disclosure Guidance and Transparency Rules of the FCA (“DTRs”), the Company confirms that, following Admission, its issued share capital will comprise 161,929,950 Ordinary Shares, each of which carries the right to vote, with no Ordinary Shares held in treasury. This figure may be used by Shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the DTRs
Cameron Pearce, Chairman of Blencowe Resources Plc commented:
“We are delighted to publish the prospectus and close the transaction to raise £2m. This provides the Company with a firm foundation to continue developing Orom-Cross graphite project and 2022 should be transformational for the Company. I would like to thank our shareholders, both old and new, and to wish everyone a happy xmas from the Blencowe team.”
For further information, please contact:
Contact details:
Blencowe Resources Plc Sam Quinn
|
Tel: +44 (0)1624 681 250 info@blencoweresourcesplc.com |
Investor Relations Sasha Sethi |
Tel: +44 (0)7891 677 441 sasha@flowscomm.com |
Brandon Hill Capital Limited Jonathan Evans |
Tel: +44 (0)20 3463 5000 jonathan.evans@brandonhillcapital.com |
First Equity Limited Jason Robertson
|
Tel: +44(0)20 7330 1883 jasonrobertson@firstequitylimited.com |
Twitter https://twitter.com/BlencoweRes
LinkedIn https://www.linkedin.com/company/72382491/admin/
Sign up for our news: http://eepurl.com/hxc9vn
#ORPH Open Orphan Plc – $13.4m Influenza HCS contract win
(AIM: ORPH), a rapidly growing specialist contract research organisation (CRO) and world leader in vaccine and antiviral testing using human challenge clinical trials , announces that hVIVO , a subsidiary of Open Orphan plc, has signed a $13.4m contract with a US-based biotechnology company to test its novel antiviral candidate using the hVIVO Influenza Human Challenge Study Model.
The study is expected to commence in H2 2022 and will be conducted at hVIVO’s state-of-the-art quarantine facilities in London. The Company expect the majority of revenues to be recognised in 2022.
The Company expects to sign an increasing number of contracts in this area as the global pandemic has highlighted the increased investment needed from governments and Big Pharma to develop effective, novel treatments for a range of infectious diseases that have potential to cause the next pandemic. Influenza is one such disease, with emergences of flu pandemics impossible to predict. Symptoms of influenza may be mild or cause severe disease, or in certain cases, death. Influenza is a serious global health threat with an estimated 1 billion cases per year, 3-5 million severe cases and 290,000 – 650,000 deaths per year.
hVIVO has two decades of experience and expertise in safely conducting challenge studies across a range of respiratory viruses, including various strains of influenza, respiratory syncytial virus (RSV), human rhinovirus (HRV – common cold virus), malaria, and asthma. In October 2020, this expanded to include the SARS-CoV-2 virus.
Cathal Friel, Executive Chairman of Open Orphan, said : ” We are delighted to announce this significant challenge study contract valued at over £10m, with a US-based biotechnology client testing its highly promising influenza antiviral candidate. This contract demonstrates the Company’s continued ability to convert its leading portfolio of challenge study models into substantial contracts, with signed contracts across a number of our challenge study models including RSV, asthma, hRV, and flu in the clinic next year. This underlines our market position as the world leader in the testing of vaccines, antivirals and respiratory products using human challenge trials.
“The recent emergence of the Omicron variant has illustrated the threat of pandemic infectious diseases, and as a result, pharma companies globally are looking to address the next cohort of infectious diseases which have potential to reach pandemic level, and are developing new therapeutics to help tackle them. Influenza is high on this list, and we expect to sign more contracts of this type as the infectious disease market grows exponentially in the coming years to be worth $250 billion by 2025. “
The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 (as implemented into English law) (“MAR”). With the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.
Interested in becoming a volunteer?
hVIVO recruits many of its volunteers for its challenge study clinical trials through its dedicated volunteer recruitment website, www.flucamp.com . By volunteering to take part in one of our studies in a safe, controlled, clinical environment under expertly supervised conditions you are playing your part to further medical research and help increase the understanding of respiratory illnesses.
Individuals interested in taking part in COVID-19 human challenge study research can learn more at www.UKCovidChallenge.com .
For further information please contact:
Open Orphan plc |
+353 (0) 1 644 0007 |
|||
Cathal Friel, Executive Chairman |
||||
Arden Partners plc (Nominated Adviser and Joint Broker) |
+44 (0) 20 7614 5900 |
|||
John Llewellyn-Lloyd / Louisa Waddell |
||||
finnCap plc (Joint Broker) |
+44 (0) 20 7220 0500 |
|||
Geoff Nash / James Thompson/ Richard Chambers |
||||
Davy (Euronext Growth Adviser and Joint Broker) |
+353 (0) 1 679 6363 |
|||
Anthony Farrell |
||||
Walbrook PR (Financial PR & IR) |
+44 (0)20 7933 8780 or openorphan@walbrookpr.com |
|||
Paul McManus/ Sam Allen/ Louis Ashe-Jepson |
+44 (0)7980 541 893 / +44 (0) 7502 558 258 / +44 (0) 7747 515393 |
#TM1 Technology Minerals – Q&A: Building battery recycling capabilities
Technology Minerals is a London-based, LSE-listed company creating a circular economy for battery metals. The company, which is also engaged in extracting raw materials required for lithium-ion (Li-ion) battery cathodes, plans to increase its lead-acid battery recycling capability to 16,000 tonnes per annum by 2022, and 5,000 tonnes per annum for Li-ion batteries in the same time frame.
Robin Brundle, chairman of Technology Minerals plc, outlines TM’s plans to recycle batteries on an industrial scale.
We start full industrial-scale production in early 2022 with two plants, the first, which is currently being installed and will be ready for commissioning in January, is focused on lead-acid battery recycling. The second on lithium-ion battery recycling is now in a manufacture test phase and will be ready for commissioning in February 2022. The sites are both located in the Midlands.
Our recently announced partnership with Slicker Recycling provides a full UK footprint for safe custodianship of collection, of all types of li-ion batteries to our processing plants as we start to build front end inventory during 2022 and grow production. In addition, the wider Slicker group is also very strong in Europe offering a mirror image of the services they offer in the UK. So that could be, at the appropriate time, important for us as we build commercial relationships in Europe.
Can you explain how your recycling process works? How do you get the value out of the so-called ‘black mass’?
The process, for both lead-acid and li-ion, starts through our nationwide collection process and the safe delivery of the batteries to our processing plants in the Midlands.
The li-ion process is industry-leading, and we own the IP on both the process and the plant design. Our process safely deals with all five types of li-ion battery sciences and in any mix or combination at the same time. The plant is modular in design and thus cost effective and each plant can process 5,000 tones per year on a single shift basis. The plant is UK designed, UK manufactured and serviced by a UK company. What sets us apart is that our process does not use pyrolysis or saline solution, and this removes risk to the working environment.
On the lead-acid side, we are industrialising and mechanising a long-established industry that has traditionally been very labour intensive. The efficiencies of the plant combined with our processes really does modernise the sector and will assist in reducing the number of batteries that are either incinerated or worse still sent to landfill.
With regard to black mass, we are working on an end solution for the UK market – it is notable that as it stands – the UK doesn’t currently have the capability to process the black mass back to its constituent parts.
Until the UK has this capability, we have global offtake partners with whom we have already shared testing samples from our process. We already have these offtake partners in place as we build black mass production through 2022.
Are your processes patented and do you intend to license them?
On the li-ion plant, we are currently reviewing our patent applications for both the plant and the process. We are focused on retaining our early to market advantage and will take the necessary steps to do so. The final design and build of the plant have taken nearly two years and is testament to the engineering innovation that we have to hand in such depth in the UK.
UK set for industrial scale battery recycling
On the lead-acid side, we are currently writing a new process to surpass any previous patents that exist. The plant has been sourced from the UK, Europe and Brazil and takes circa eight months from order to completion.
What relationship do you have with Gigafactories?
We have a number of ongoing discussions with the battery OEMs which are at various stages of maturity, and also the tier one auto manufacturers to become their respective partners of choice. Certainly, we aim to build out our plants in line with customer requirements and, where appropriate, creating a bespoke recycling capability on-site which utilises the benefits of our modular processing plant and technology.
You are currently looking at Li-ion batteries from EVs. Do you plan on using other sources (laptops, tablets etc) of battery?
This proprietary process enables us to put all five sciences of lithium-ion batteries through our process, whether that is from portable devices, laptops, e-bikes, through to the heavier end of automotive and energy stations. Each battery type has a slightly different science, and our process allows us to safely recycle any combination through to the output of the ‘black mass’ material, which is rich in a number of the key metals which goes onto the final process of refining back to their respective form.
What markets are you targeting?
Because of the ability of the process to handle all five sciences in lithium-ion batteries we are not restricted as to sector or industry, from the perspective of local authorities looking for safe handling and recycling, through to the automotive OEMs, fleet management and auto dealership networks we have the logistic solution and the re-purposing and then recycling engineering process that really does embrace a circular economy solution for end-of-use and end-of-life batteries.
More broadly, what percentage of your mined products do you expect to introduce into the mix over time?
Our whole strategy is focused on the circular economy, and specifically in the battery sector, and as such we are targeting 100 per cent of all materials being used, be that mined or recycled.
The focus for our recycling operation longer term is on the UK and European markets with a view to grow to 20,000 tonnes of lithium-ion batteries and 60,000 tonnes of lead-acid batteries respectively per annum over the next decade.
The largest market opportunity is in the automotive industry, with 800,000 tonnes of battery per year, equating to ~70 per cent of the battery market in Europe
Lead-acid is the largest battery type with 831,000 tonnes, comprising over 72 per cent of the battery market in Europe.
#ECHO Echo Energy – Operational Update
Echo Energy, the Latin American focused energy company, is pleased to provide an operational update regarding its Santa Cruz Sur assets, onshore Argentina for Q4 2021 to 30 November 2021.
Daily operations across the asset base in Santa Cruz Sur and the delivery of produced gas to industrial customers under contract have continued uninterrupted during the first two months of Q4 2021. Production over the period from 1 January 2021 to 30 November 2021 reached an aggregate of 523,735 boe net to Echo, including 74,605 bbls of oil and condensate and 2,695 mmscf of gas.
As a result of the completion of capacity increasing infrastructure works, gas production in November 2021 averaged 7.1 MMscf/d net to Echo, an increase over the 6.7 MMscf/d net production rate during the previous month.
Net liquids production in the first two months of Q4 2021 averaged 255 bopd, and is an increase of 31% over Q1 2021 levels prior to the commencement of production optimisation and the bringing of shut in wells back on line. The benefit of both infrastructure maintenance and the previously announced commercial focus on high-quality blends at Santa Cruz Sur has also led to an increased frequency of oil sales during Q4 2021 to date, with total liquids sales net to Echo in quarter four to date of 16,855 bbls (Q3 2021 total of: 15,050 bbls). This increase in liquids production has helped to offset the expected natural decline in gas production over the year.
The Company looks forward to updating shareholders on production levels on a quarterly basis going forward.
For further information, please contact:
Echo Energy Martin Hull, Chief Executive Officer
|
via Vigo Communications |
Vigo Consulting (IR & PR Advisor) Patrick d’Ancona Chris McMahon
|
+44 (0) 20 7390 0230 |
Cenkos Securities (Nominated Adviser) Ben Jeynes Katy Birkin
|
+44 (0) 20 7397 8900 |
Shore Capital (Corporate Broker)
|
+44 (0) 20 7408 4090 |
UK Investor Magazine podcast – Berkeley Group #BKG, UK Property, Technology Minerals #TM1, Revolution Bars #RBG & Conroy Gold #CGNR with Alan Green
UK Investor Magazine – Berkeley Group #BKG, UK Property, Technology Minerals #TM1, Revolution Bars #RBG and Conroy Gold #CGNR with Alan Green.
Mosman Oil & Gas #MSMN – Winters-2 and Stanley-5 Update
Mosman Oil and Gas Limited (AIM: MSMN) the oil exploration, development and production company, announces an update on the Winters-2 and Stanley-5 wells in Polk County, East Texas.
The Winters-2 well is being recompleted in the upper few feet of the current Wilcox zone to limit the production of water. This zone has demonstrated the potential to produce oil, gas and water but it is believed that the water is coming from the lower part of the perforated zone. Mosman plans to cement squeeze the lower perforations to limit the water influx. If this is not successful, the well will be recompleted in another zone.
At the Stanley-5 well, testing has been carried out on the first potential zone in the lower most part of the well which produced mainly water with some gas at sub-economic rates from a depth of approximately 4850 feet. The well will be reperforated up-hole to a Yegua zone at an approximate depth of 4800 feet. The sand has been known to produce oil in surrounding wells and Mosman expects the test will be carried out in the coming days. There are multiple potential hydrocarbon bearing sands in this well and it is normal oilfield practice to start testing from the lowermost zone.
There is one service rig being used on Winters-2 which will be moved to recomplete Stanley-5. Once work is complete, it can then be used on other workovers which, as previously noted, continue to be considered in order to boost production, including wells on the Stanley and Duff leases.
Qualified Person’s Statement
The information contained in this announcement has been reviewed and approved by Andy Carroll, Technical Director for Mosman, who has over 35 years of relevant experience in the oil industry. Mr. Carroll is a member of the Society of Petroleum Engineers.
Market Abuse Regulation (MAR) Disclosure
The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 (‘MAR’) which has been incorporated into UK law by the European Union (Withdrawal) Act 2018. Upon the publication of this announcement via Regulatory Information Service (‘RIS’), this information is now considered to be in the public domain.
Enquiries:
Mosman Oil & Gas Limited John W Barr, Executive Chairman Andy Carroll, Technical Director |
NOMAD and Broker SP Angel Corporate Finance LLP Stuart Gledhill / Richard Hail / Adam Cowl +44 (0) 20 3470 0470 |
Alma PR Justine James / Joe Pederzolli +44 (0) 20 3405 0205 +44 (0) 7525 324431 |
Joint Broker Monecor (London) Ltd trading as ETX Capital Thomas Smith 020 7392 1432 |